Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma

Suppression of the Nitric Oxide Pathway in Metastatic Renal Cell Carcinoma Patients Receiving Vascular Endothelial Growth Factor–Signaling Inhibitors

Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice‐based on medical chart review